Discontinued OTC asthma med may make comeback

Share this article:

OTC inhaler Primatene Mist officially left the building in August 2013, just over two years after it was banned because the prescription-free asthma inhaler's chlorofluorocarbons violated environmental regulations.

Regulatory Focus reports that the last of the inhalers was officially off the market this summer, but that a Federal Register notice indicates the FDA's Pulmonary-Allergy Drugs Advisory Committee is set to consider an OTC replacement Feb. 25. The new Primatene Mist is currently operating under the name Primatene HFA.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.